As the pro-inflammatory effect of the NLRP3 inflammasome is deleterious, the discovery of effective and specific drugs that alter NLRP3 inflammasome function has the potential to improve the symptoms of sepsis and AKI. Here, NLRP3 is linked to acute kidney injury.